These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15915470)

  • 41. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of AST to the platelet ratio index.
    Fabris C; Smirne C; Toniutto P; Colletta C; Rapetti R; Minisini R; Falleti E; Pirisi M
    Clin Biochem; 2006 Apr; 39(4):339-43. PubMed ID: 16487951
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Utility of 2 biochemical models predictive of liver fibrosis grade in prison inmates with hepatitis C].
    Portilla J; López-Burgos A; Saiz-De-La-Hoya-Zamácola P; Sánchez-Payá J; Bedía-Collantes M; Faraco-Atienzar I; Lissen E
    Gastroenterol Hepatol; 2009; 32(6):387-94. PubMed ID: 19477553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Noninvasive diagnosis of cirrhosis in chronic hepatitis C based on standard laboratory tests.
    Lackner C; Struber G; Bankuti C; Bauer B; Stauber RE
    Hepatology; 2006 Feb; 43(2):378-9; author reply 379. PubMed ID: 16440344
    [No Abstract]   [Full Text] [Related]  

  • 45. [Do prothrombin time, transaminases, and platelet count predict the severity of fibrosis in viral liver diseases?].
    Mohamed MA; Majda E; Mohamed K; Bechir Z; Sana K; Ehsène BB; Samia C
    Tunis Med; 2005 Jul; 83(7):400-3. PubMed ID: 16220696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The utility of aspartate aminotransferase/platelet ratio index in HIV/hepatitis C-co-infected patients.
    Shastry L; Wilson T; Lascher S; Nord JA
    AIDS; 2007 Nov; 21(18):2541-3. PubMed ID: 18025895
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease.
    Mohamadnejad M; Montazeri G; Fazlollahi A; Zamani F; Nasiri J; Nobakht H; Forouzanfar MH; Abedian S; Tavangar SM; Mohamadkhani A; Ghoujeghi F; Estakhri A; Nouri N; Farzadi Z; Najjari A; Malekzadeh R
    Am J Gastroenterol; 2006 Nov; 101(11):2537-45. PubMed ID: 17029616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Non-invasive detection of liver fibrosis in patients with chronic hepatitis C].
    Aiglová K; Ehrmann J; Ehrmann J
    Cas Lek Cesk; 2007; 146(6):542-5. PubMed ID: 17650594
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease.
    Hartley JL; Brown RM; Tybulewicz A; Hayes P; Wilson DC; Gillett P; McKiernan P
    J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):217-21. PubMed ID: 16877988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
    Stránský J; Ryzlová M; Striteský J; Horák J
    Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Value of AST/ALT ratio as fibrotic predictor in chronic hepatitis C.
    Park G; Jones DB; Katelaris P
    Am J Gastroenterol; 2005 Jul; 100(7):1623-4; author reply 1624. PubMed ID: 15984996
    [No Abstract]   [Full Text] [Related]  

  • 53. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases.
    Coco B; Oliveri F; Maina AM; Ciccorossi P; Sacco R; Colombatto P; Bonino F; Brunetto MR
    J Viral Hepat; 2007 May; 14(5):360-9. PubMed ID: 17439526
    [TBL] [Abstract][Full Text] [Related]  

  • 54. APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: more questions than answers.
    Su TH; Kao JH; Chen DS
    Hepatology; 2007 Jun; 45(6):1586-7; author reply 1587-8. PubMed ID: 17538939
    [No Abstract]   [Full Text] [Related]  

  • 55. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study.
    Ramakrishna B; Mukhopadhya A; Kurian G
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1734-8. PubMed ID: 18713304
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.
    Castéra L; Le Bail B; Roudot-Thoraval F; Bernard PH; Foucher J; Merrouche W; Couzigou P; de Lédinghen V
    J Hepatol; 2009 Jan; 50(1):59-68. PubMed ID: 19013661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes.
    Macías J; Girón-González JA; González-Serrano M; Merino D; Cano P; Mira JA; Arizcorreta-Yarza A; Ruíz-Morales J; Lomas-Cabeza JM; García-García JA; Corzo JE; Pineda JA
    Gut; 2006 Mar; 55(3):409-14. PubMed ID: 16118349
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spontaneous HBsAg seroclearance confers excellent prognosis except in patients with cirrhosis.
    Chen YC; Liaw YF
    Hepatology; 2004 Aug; 40(2):501; author reply 501-2. PubMed ID: 15368463
    [No Abstract]   [Full Text] [Related]  

  • 59. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversibility of cirrhosis in HIV/HBV coinfection.
    Mallet VO; Dhalluin-Venier V; Verkarre V; Correas JM; Chaix ML; Viard JP; Pol S
    Antivir Ther; 2007; 12(2):279-83. PubMed ID: 17503671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.